Furthermore, our in vivo studies exhibited that CILP2 knockdown in CRC cells significantly downregulated tumour nodules, tumour weight, and ascites, indicating a decreased ability for cancer cell dissemination and growth both in vitro and in vivo. The gene discussed is CILP2; the disease is cancer.